Qnovia, Inc. announced its CEO is speaking publicly to FDA and NIH at the joint agency public meeting on Advancing Smoking Cessation today at FDA's White Oak Campus. Qnovia is a pharmaceutical company ...
Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW171 in treatment of ovarian cancer, non-small ...
Endospan, a pioneer in endovascular solutions for the Aortic Arch, today announced the completion of enrollment for the primary arm of its TRIOMPHE Investigational Device Exemption (IDE) clinical ...